Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
- Conditions
- Axillary Hyperhidrosis
- Interventions
- Drug: Sofpironium Bromide, 15%Drug: Vehicle
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 351
- Registration Number
- NCT03948646
- Locations
- 🇺🇸
First OC Dermatology, Fountain Valley, California, United States
🇺🇸Aventiv Research Inc., Dublin, Ohio, United States
🇺🇸Florida Academic Dermatology Centers Research & Education, LLC, Coral Gables, Florida, United States
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
- Conditions
- Axillary Hyperhidrosis
- Interventions
- Drug: Sofpironium Bromide Gel, 15%Drug: Vehicle
- First Posted Date
- 2019-02-11
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 350
- Registration Number
- NCT03836287
- Locations
- 🇺🇸
Lawrence J Green, MD LLC, Rockville, Maryland, United States
🇺🇸Dermatology Research Associates, Los Angeles, California, United States
🇺🇸International Dermatology Research, Inc., Miami, Florida, United States
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: BTX 1204Drug: Vehicle
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 200
- Registration Number
- NCT03824405
- Locations
- 🇺🇸
Clinical Science Institute, Santa Monica, California, United States
🇺🇸Aventiv Research Inc - Dublin, Dublin, Ohio, United States
🇺🇸T. Joseph Raoff MD Inc. / Encino Research Center, Encino, California, United States
A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Drug: Sofpironium Bromide Gel, 15%
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 21
- Registration Number
- NCT03785587
- Locations
- 🇺🇸
Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, United States
A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
- Conditions
- Primary Axillary Hyperhidrosis
- Interventions
- Drug: Sofpironium Bromide Gel, 5%Drug: Sofpironium Bromide Gel, 15%
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT03627468
- Locations
- 🇺🇸
Skin Care Research, Inc., Boca Raton, Florida, United States
🇺🇸Grekin Skin Institute, Warren, Michigan, United States
🇺🇸Center for Clinical and Cosmetic Research, Aventura, Florida, United States
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: BTX 1503Drug: Vehicle
- First Posted Date
- 2018-06-29
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 368
- Registration Number
- NCT03573518
- Locations
- 🇺🇸
Applied Research Center of Arkansas, Little Rock, Arkansas, United States
🇺🇸Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States
🇺🇸Encino Research Center, Encino, California, United States
A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
- Conditions
- Hyperhidrosis
- Interventions
- Drug: BBI-4000 gel, 5%Drug: BBI-4000 gel, 10%Drug: Vehicle (Placebo)Drug: BBI-4000 gel, 15%
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 227
- Registration Number
- NCT03024255
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
- Conditions
- Hyperhidrosis
- Interventions
- Other: Vehicle gelDrug: BBI-4000, 15%
- First Posted Date
- 2016-02-15
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 50
- Registration Number
- NCT02682238
- Locations
- 🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
🇺🇸TCR Medical Corporation, San Diego, California, United States
A Non-Interventional Study To Assess Sweating
- Conditions
- Hyperhidrosis
- Interventions
- Other: gravimetric
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT02552199
- Locations
- 🇺🇸
Carpinteria Dermatology, Carpinteria, California, United States
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
- Conditions
- Hyperhidrosis
- Interventions
- Drug: BBI-4000 Gel, 5%Drug: BBI-4000 Gel, 10%Drug: BBI-4000 Gel, 15%Drug: Vehicle
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Botanix Pharmaceuticals
- Target Recruit Count
- 189
- Registration Number
- NCT02336503
- Locations
- 🇺🇸
Center for Clinical and Cosmetic Research, Aventura, Florida, United States
🇺🇸The Center for Skin Research, Houston, Texas, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States